Crescent Biopharma (CBIO) Other Working Capital Changes (2013 - 2026)
Crescent Biopharma (CBIO) reported Other Working Capital Changes of -$101000.0 for Q1 2026, up 54.5% on a QoQ basis from -$222000.0 in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of Other Working Capital Changes data on file, last reported at -$101000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed N/A year-over-year to -$101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$263000.0 (up 48.88% YoY) and the FY2025 annual result came in at -$162000.0, up 78.15% from the prior year.
- Other Working Capital Changes rose to -$101000.0 in Q1 2026 per CBIO's latest filing, from -$222000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $240103.0 in Q1 2023 and bottomed at -$762531.0 in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$230847.0 (2022), against an average of -$188363.7.
- The widest annual swing landed in 2022, when Other Working Capital Changes tumbled 538.98%; it then soared 200.17% in 2023.
- Tracing CBIO's Other Working Capital Changes over 5 years: stood at -$261549.0 in 2022, then soared by 74.58% to -$66486.0 in 2023, then sank by 673.82% to -$514480.0 in 2024, then soared by 56.85% to -$222000.0 in 2025, then jumped by 54.5% to -$101000.0 in 2026.
- Per Business Quant, the three latest CBIO Other Working Capital Changes figures stand at -$101000.0 (Q1 2026), -$222000.0 (Q4 2025), and $46000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101,000.00 |
| Mar 31, 2026 | -101,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2024 | -514,480.00 |
| Jun 30, 2024 | -514,480.00 |
| Mar 31, 2024 | -11,971.00 |
| Mar 31, 2024 | -11,971.00 |
| Dec 31, 2023 | -66,486.00 |
| Dec 31, 2023 | -66,486.00 |
| Sep 30, 2023 | -257,268.00 |
| Sep 30, 2023 | -257,268.00 |
| Jun 30, 2023 | -762,531.00 |
| Jun 30, 2023 | -762,531.00 |
| Mar 31, 2023 | 240,103.00 |
| Mar 31, 2023 | 240,103.00 |
| Dec 31, 2022 | -261,549.00 |
| Dec 31, 2022 | -261,549.00 |
| Sep 30, 2022 | -254,864.00 |
| Sep 30, 2022 | -254,864.00 |
| Jun 30, 2022 | -245,352.00 |
| Jun 30, 2022 | -245,352.00 |
| Mar 31, 2022 | -239,694.00 |
| Mar 31, 2022 | -239,694.00 |
| Dec 31, 2021 | -40,932.00 |
| Dec 31, 2021 | -40,932.00 |
| Sep 30, 2021 | -886,131.00 |
| Sep 30, 2021 | -886,131.00 |
| Jun 30, 2021 | 437,349.00 |
| Jun 30, 2021 | 437,349.00 |
| Mar 31, 2021 | -214,810.00 |
| Mar 31, 2021 | -214,810.00 |
| Dec 31, 2020 | -2.49 Mn |
| Dec 31, 2020 | -2.49 Mn |
| Sep 30, 2020 | 219,406.00 |
| Sep 30, 2020 | 219,406.00 |
| Jun 30, 2020 | -620,923.00 |
| Jun 30, 2020 | -620,923.00 |
| Mar 31, 2020 | -191,994.00 |
| Mar 31, 2020 | -191,994.00 |
| Dec 31, 2019 | 2.59 Mn |
| Dec 31, 2019 | 2.59 Mn |
| Sep 30, 2019 | -565,365.00 |
| Sep 30, 2019 | -565,365.00 |
| Jun 30, 2019 | -527,350.00 |
| Jun 30, 2019 | -527,350.00 |
| Mar 31, 2019 | 561,897.00 |
| Mar 31, 2019 | 561,897.00 |
| Dec 31, 2018 | -253,662.00 |
| Dec 31, 2018 | -253,662.00 |
| Sep 30, 2018 | -655,049.00 |
| Sep 30, 2018 | -655,049.00 |
| Jun 30, 2018 | -17,324.00 |
| Jun 30, 2018 | -17,324.00 |
| Mar 31, 2018 | -17,325.00 |
| Mar 31, 2018 | -17,325.00 |
| Dec 31, 2017 | 2.28 Mn |
| Dec 31, 2017 | 2.28 Mn |
| Sep 30, 2017 | 513,592.00 |
| Sep 30, 2017 | 513,592.00 |
| Jun 30, 2017 | -194,908.00 |
| Jun 30, 2017 | -194,908.00 |
| Mar 31, 2017 | 218,560.00 |
| Mar 31, 2017 | 218,560.00 |
| Dec 31, 2016 | -761,213.00 |
| Dec 31, 2016 | -761,213.00 |
| Sep 30, 2016 | -209,303.00 |
| Sep 30, 2016 | -209,303.00 |
| Jun 30, 2016 | 765,654.00 |
| Jun 30, 2016 | 765,654.00 |
| Mar 31, 2016 | 241,555.00 |
| Mar 31, 2016 | 241,555.00 |
| Dec 31, 2015 | -276,424.00 |
| Dec 31, 2015 | -276,424.00 |
| Sep 30, 2015 | 183,383.00 |
| Sep 30, 2015 | 183,383.00 |
| Jun 30, 2015 | -242,229.00 |
| Jun 30, 2015 | -242,229.00 |
| Mar 31, 2015 | -139,169.00 |
| Mar 31, 2015 | -139,169.00 |
| Dec 31, 2014 | 328,428.00 |
| Dec 31, 2014 | 328,428.00 |
| Sep 30, 2014 | -293,893.00 |
| Sep 30, 2014 | -293,893.00 |
| Jun 30, 2014 | 162,695.00 |
| Jun 30, 2014 | 162,695.00 |
| Mar 31, 2014 | -1.85 Mn |
| Mar 31, 2014 | -1.85 Mn |
| Dec 31, 2013 | -4.85 Mn |
| Dec 31, 2013 | -4.85 Mn |
| Sep 30, 2013 | 1.09 Mn |
| Sep 30, 2013 | 1.09 Mn |
| Jun 30, 2013 | -182,662.00 |
| Jun 30, 2013 | -182,662.00 |
| Mar 31, 2013 | -54,889.00 |
| Mar 31, 2013 | -54,889.00 |